In Utero Antiretroviral Exposure and Risk of Neurodevelopmental Problems in HIV-Exposed Uninfected 5-Year-Old Children.
Sign Up to like & getrecommendations! Published in 2023 at "AIDS patient care and STDs"
DOI: 10.1089/apc.2022.0189
Abstract: Studies have observed neurodevelopmental (ND) challenges among young children perinatally HIV-exposed yet uninfected (CHEU) with in utero antiretroviral (ARV) exposure, without clear linkage to specific ARVs. Atazanavir (ATV) boosted with ritonavir has been a preferred… read more here.
Keywords: risk signals; year old; risk; utero antiretroviral ... See more keywords